insiderbuyingselling Posted - 1 week ago

$BVS new insider selling: 1325 shares. http://insiderbuyingselling.com/?t=BVS

insiderbuyingselling Posted - 1 month ago

$BVS new insider selling: 1217 shares. http://insiderbuyingselling.com/?t=BVS

Stocksrunner Posted - 1 month ago

Price Target Revisions $NVDA - BofA powers up NVIDIA's target amid AI euphoria. $CLPT - ClearPoint Neuro's trajectory gains clarity with target hiking to $9 on surging momentum. $BVS - Bioventus shares get a solid $9 boost after impressive Q4 show. $BWMN - Bowman Consulting's growth trajectory earns a $54 target raise. Time to consult the bulls?

Tai2301 Posted - 1 month ago

$BVS Picked up an entry at 5.35. Let's go!!!

tradethehalt Posted - 1 month ago

$BVS trade halt (LUDP) was alerted to our Members at 9:35am EDT. Halt price: $5.32 Vol: 95.65K.

HaltTradeAlert Posted - 1 month ago

$BVS Halt Time: 09:35:24 Issue Symbol: BVS Reason Code: LUDP Stock Price: $5.32 Market Cap: 334.978M Volume: 95,336 Relative Volume: 0.72 Shares Float: 20.03M Get this alert real time and sent to your phone just like a text by going to our website and joining our community for FREE! We just launched this service! Help us spread the word ! www.HaltTradeAlert.com

TrashPandr Posted - 1 month ago

$BVS be nice to see this get some traction. Today. Not a lot of standouts today.

MakingDreamsReality Posted - 1 month ago

PM mOOvers 👀 $RERE - ATRenew announces $20 million share repurchase program, ATRenew Q4 Adj EPS $0.08 Up From $0.02 YoY, Sales $545.60M Up From $432.23M YoY $LFMD - LifeMD Q4 2023 Adj EPS $0.15 Beats $(0.14) Estimate, Sales $44.860M Beat $40.494M Estimate $BCDA -BioCardia Announces CMS Approval of Coverage for CardiAMP Cell Therapy Confirmatory Phase III Heart Failure Study $SIGA - SIGA Declares Special Cash Dividend of $0.60 Per Share $BVS - Bioventus Q4 Adjusted EPS $0.07 Beats $0.02 Estimate, Sales $135.42M Beat $123.96M Estimate, Bioventus Expects 2024 Sales Of $520M-$535M Versus Consensus Of $517.74M, With Adjusted EPS Of $0.12-$0.20 Versus Consensus Of $0.33 And Adjusted EBITDA Of $89M-$94M

tradingtwenty Posted - 1 month ago

$BVS has trended 11 times in the past 24 hours (based on 5 minute intervals). Latest article on Mar 12, 2024 07:30 AM: Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results Link: https://tradingtwenty.com/news/390720/bioventus-announces-fourth-quarter-and-full-year-2023-financial-results

Tokenist Posted - 1 month ago

🚨EARNINGS ALERT🚨 Notable earnings released for today: Miniso $MNSO: $2.04 EPS vs $1.86 est. / $3.84B Revenue vs $3.77B est Kohl’s Corp $KSS: $1.67 EPS vs $1.27 est. / $5.71B Revenue vs $5.8B est Bioventus $BVS: $0.07 vs $0.0191 est. / $135.42M Revenue vs $123.96M est

epsguid Posted - 1 month ago

$BVS reported earnings of $0.07, consensus was $0.06 via @eWhispers #epsbeat http://eps.sh/d/bvs

DonCorleone77 Posted - 1 month ago

$BVS Bioventus sees 2024 non-GAAP EPS 12c-20c, consensus 33c Bioventus introduced its financial guidance for full-year 2024. The Company expects: Net sales of $520 million to $535 million; Adjusted EBITDA of $89 million to $94 million; Non-GAAP EPS of $0.12 to $0.20. Revenue consensus $517.82M.

DonCorleone77 Posted - 1 month ago

$BVS Bioventus reports Q4 adjusted EPS 7c, consensus 2c Reports Q4 revenue $135.4M, consensus $123.96M. "We returned to revenue growth, significantly improved adjusted EBITDA, and further enhanced our liquidity position as a result of our team's strong execution in the fourth quarter of 2023," commented Rob Claypoole, Bioventus' President and Chief Executive Officer. "After immersing myself in the business over the last two months, it's clear to me that Bioventus has a solid foundation of market-leading products and compelling growth prospects. Going forward, we remain committed to unlocking our full potential to help patients and create value for shareholders."

Stock_Titan Posted - 1 month ago

$BVS Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results https://www.stocktitan.net/news/BVS/bioventus-announces-fourth-quarter-and-full-year-2023-financial-ky40q3m7sddg.html

STR33 Posted - 1 month ago

$BVS Only a reminder : 06/12/2023 - 08:00 DURHAM, N.C., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has agreed to a nationwide contract with Aetna™ Medicare Advantage plans. Beginning January 1, 2024, over 3 million Aetna™ Medicare Advantage plan members will have access to DUROLANE to treat knee osteoarthritis (OA) pain. DUROLANE, is a single-injection hyaluronic acid (HA)-based joint-fluid treatment for patients. DUROLANE will be one of two single-injection HA products under contract. OA involves the breakdown, or degeneration, of cartilage and the synovial fluid that cushions and lubricates joint tissues. Injection treatments of HA-based products, such as DUROLANE, help manage knee OA pain.

Doozio Posted - 1 month ago

$BVS 🧠⏰ is still…..

Stock_Titan Posted - 1 month ago

$BVS Bioventus to Report Fourth Quarter of Fiscal Year 2023 Financial Results on March 12, 2024 https://www.stocktitan.net/news/BVS/bioventus-to-report-fourth-quarter-of-fiscal-year-2023-financial-yy52sy8dh43i.html

Readingthecharts Posted - 2 months ago

$BVS entry when this closes above 5.14...PT $7.45

VirmoMopire Posted - 01/30/24

$BVS Just spotted some interesting activity on this one. 🧐

cctranscripts Posted - 3 months ago

R. Scott Barry just provided an update on share ownership of Bioventus Inc. https://www.conferencecalltranscripts.org/summary/?id=12884284 $BVS

Last10K Posted - 3 months ago

$BVS just filed with the SEC a New Agreement and a Financial Exhibit https://last10k.com/sec-filings/BVS/0001193125-24-010779.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=BVS

cctranscripts Posted - 3 months ago

Entry into a Material Definitive https://www.conferencecalltranscripts.org/summary/?id=12879164 $BVS

risenhoover Posted - 3 months ago

$BVS / Bioventus files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 18, 2024 Bioventus Inc. ( https://fintel.io/doc/sec-bioventus-inc-1665988-8k-2024-january-19-19741-7397?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

STCKPRO Posted - 3 months ago

$BVS NEW ARTICLE : Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility https://stck.pro/news/BVS/73096189/

Last10K Posted - 3 months ago

$BVS just filed with the SEC a Event for Officers https://last10k.com/sec-filings/BVS/0001193125-24-007640.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=BVS

cctranscripts Posted - 3 months ago

Departure of Directors or Certain https://www.conferencecalltranscripts.org/summary/?id=12864397 $BVS

risenhoover Posted - 3 months ago

$BVS / Bioventus files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 9, 2024 Bioventus Inc. (E https://fintel.io/doc/sec-bioventus-inc-1665988-8k-2024-january-12-19734-1625?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

cctranscripts Posted - 3 months ago

Bioventus Inc.'s President and CEO was just granted 1,225,000 options and restricted shares https://www.conferencecalltranscripts.org/summary/?id=12864297 $BVS

cctranscripts Posted - 3 months ago

Bioventus Inc.'s President and CEO just declared owning 0 shares of Bioventus Inc. https://www.conferencecalltranscripts.org/summary/?id=12864217 $BVS

cctranscripts Posted - 3 months ago

Securities to be offered to employees in employee benefit plans https://www.conferencecalltranscripts.org/summary/?id=12853273 $BVS